Why do patients with metastatic breast cancer (MBC) continue to have bone destruction despite bisphosphonate (BP) use? A pathologic review Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- March 2006
has subject area
- 06 Biological Sciences (FoR)
- 09 Engineering (FoR)
- 11 Medical and Health Sciences (FoR)
- Endocrinology & Metabolism (Science Metrix)
published in
- Bone Journal